| Safety Profile of Applied 100% Manuka Honey in Tympanoplasty (NCT05657717) | Fakultas Kedokteran Universitas Indonesia | 2021-07-13 |
| A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT (NCT04684368) | Children's Oncology Group | 2021-07-13 |
| Propolis-based Product (FARINGEL PLUS) for Oral Mucositis in Palliative Care (NCT04911335) | Campus Bio-Medico University | 2021-07-13 |
| Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial (NCT05165225) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-07-13 |
| Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults (NCT04475991) | Hospital General de México Dr. Eduardo Liceaga | 2021-07-13 |
| Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM (NCT04653246) | Jacob Laubach, MD | 2021-07-13 |
| Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study (NCT05017103) | M.D. Anderson Cancer Center | 2021-07-13 |
| Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] (NCT04945772) | Nanoscope Therapeutics Inc. | 2021-07-13 |
| Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer (NCT04737109) | David VanderWeele | 2021-07-13 |
| Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis (NCT04551131) | St. Jude Children's Research Hospital | 2021-07-13 |
| UW Withdraw From Tobacco Study (NCT04969198) | University of Wisconsin, Madison | 2021-07-13 |
| The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC) (NCT04961918) | Sun Yat-sen University | 2021-07-13 |
| Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy (NCT04477616) | The First Affiliated Hospital with Nanjing Medical University | 2021-07-13 |
| A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC) (NCT04787328) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-07-13 |
| Effects of a Composition on the Oral Microbiome, pH, Nitrite/Nitrate Ratio, Elastases and Inflammation in Oral Dysbiosis (NCT05463484) | Mucosa Innovations, S.L. | 2021-07-13 |
| Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19) (NCT04760730) | R-Pharm | 2021-07-13 |
| NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome (NCT04977388) | Stephen G. Kaler, MD | 2021-07-12 |
| A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer (NCT04951115) | Weill Medical College of Cornell University | 2021-07-12 |
| A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma (NCT04983810) | Cyclacel Pharmaceuticals, Inc. | 2021-07-12 |
| Immunotherapy for Third Line Metastatic Colorectal Cancer (NCT04444622) | Mirror Biologics, Inc. | 2021-07-12 |
| PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE (NCT04601467) | National University Heart Centre, Singapore | 2021-07-12 |
| A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL (NCT04496349) | Ascentage Pharma Group Inc. | 2021-07-12 |
| EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer (NCT04892472) | NovoCure GmbH | 2021-07-12 |
| Booster Vaccination Against COVID-19 (NCT04979949) | Health Institutes of Turkey | 2021-07-12 |
| To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213) (NCT04629508) | Incyte Corporation | 2021-07-12 |
| A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) (NCT04857034) | Bristol-Myers Squibb | 2021-07-12 |
| Universal Anti-Viral Vaccine for Healthy Elderly Adults (NCT04441047) | Mirror Biologics, Inc. | 2021-07-12 |
| Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis (NCT04863014) | Regeneron Pharmaceuticals | 2021-07-12 |
| A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection (NCT04969172) | Eli Sprecher, MD | 2021-07-11 |
| Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection (NCT04856085) | Vir Biotechnology, Inc. | 2021-07-11 |
| Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy (NCT04692103) | University of Washington | 2021-07-10 |
| Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study (NCT03110484) | Samsung Medical Center | 2021-07-09 |
| Suppressive Antibacterial Therapy With Once-Weekly Secnidazole Granules to Prevent Recurrent Bacterial Vaginosis; A Pilot Study (NCT05033743) | Indiana University | 2021-07-09 |
| Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis (NCT04948203) | University of Chicago | 2021-07-09 |
| HYDROxychloroquine in Syndrome Primary AntiPhospholipid (NCT04275778) | Assistance Publique - Hôpitaux de Paris | 2021-07-09 |
| RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome (NCT03684564) | University College, London | 2021-07-09 |
| Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases (NCT04808752) | Zhejiang Cancer Hospital | 2021-07-09 |
| Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma (NCT04776395) | Emory University | 2021-07-09 |
| Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer (NCT05035914) | Guangzhou University of Traditional Chinese Medicine | 2021-07-09 |
| Ad26.ZEBOV Booster in Children Previously Vaccinated With Ad26.ZEBOV and MVA-BN-Filo (EBOVAC Booster Study) (NCT04711356) | London School of Hygiene and Tropical Medicine | 2021-07-08 |
| Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients (NCT04752384) | Medical College of Wisconsin | 2021-07-08 |
| Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract Cancer (NCT04727541) | AIO-Studien-gGmbH | 2021-07-08 |
| A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment (NCT04872634) | NKMAX Co., Ltd. | 2021-07-08 |
| Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster (NCT04992182) | Universidad del Desarrollo | 2021-07-08 |
| Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai (NCT04524390) | Mirum Pharmaceuticals, Inc. | 2021-07-08 |
| ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT05010122) | M.D. Anderson Cancer Center | 2021-07-08 |
| pAF for the Treatment of Osteoarthritis (NCT04886960) | University of Utah | 2021-07-08 |
| Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA (NCT05103618) | Andrew Newberg | 2021-07-08 |
| Pozelimab and Cemdisiran Combination Therapy in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Switch From Eculizumab Therapy (NCT04888507) | Regeneron Pharmaceuticals | 2021-07-08 |
| The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies. (NCT04949191) | Incyte Corporation | 2021-07-08 |
| Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002) (NCT04807140) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-07-08 |
| Efficacy and Safety Study of Ketorolac / Pitofenone / Fenpiverinium for the Treatment of Patients With Pain After Surgical Abdominal and Pelvic Operations (NCT05607641) | Darnitsa Pharmaceutical Company | 2021-07-07 |
| A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (NCT04936035) | Alnylam Pharmaceuticals | 2021-07-07 |
| Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial) (NCT04169074) | University of Arizona | 2021-07-07 |
| Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy (NCT04037462) | VA Office of Research and Development | 2021-07-07 |
| Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries (NCT04565925) | The University of Texas Medical Branch, Galveston | 2021-07-07 |
| Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy (NCT04892953) | M.D. Anderson Cancer Center | 2021-07-07 |
| Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine Tumors (NCT04538378) | National Cancer Institute (NCI) | 2021-07-07 |
| Roflumilast to Treat Cognitive Sequela After Stroke (NCT04854811) | Maastricht University | 2021-07-07 |
| A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa (NCT04856930) | Vanda Pharmaceuticals | 2021-07-07 |
| Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract (NCT04633187) | Enanta Pharmaceuticals, Inc | 2021-07-07 |
| Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5) (NCT05055635) | University of Aarhus | 2021-07-07 |
| SPARK-ALL: Calaspargase Pegol in Adults With ALL (NCT04817761) | Institut de Recherches Internationales Servier | 2021-07-07 |
| A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia (NCT04964557) | AstraZeneca | 2021-07-07 |
| Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT04734990) | M.D. Anderson Cancer Center | 2021-07-07 |
| Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy (NCT04693715) | Revalesio Corporation | 2021-07-07 |
| Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer (NCT05179889) | Chungnam National University Hospital | 2021-07-06 |
| Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors (NCT04934514) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2021-07-06 |
| A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults (NCT04956575) | ModernaTX, Inc. | 2021-07-06 |
| Selinexor in Combination With Thalidomide and Dexamethasone in RRMM (NCT04891744) | Li Zheng | 2021-07-06 |
| Administration of Antibiotic Prophylaxis for Transperineal Prostate Biopsy in Cipto Mangunkusumo Hospital (NCT04985110) | Indonesia University | 2021-07-06 |
| Memantine Augmentation of Targeted Cognitive Training in Schizophrenia (NCT04857983) | University of California, San Diego | 2021-07-06 |
| Efficacy of ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse Regimen on MGI, PI and BOP (NCT05258721) | Rowpar Pharmaceuticals, Inc. | 2021-07-06 |
| Antithrombin III in Infectious Disease Caused by COVID-19 (NCT04899232) | Enrique Ginzburg | 2021-07-06 |
| Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes (NCT04962906) | Ministerio de Salud de Ciudad Autónoma de Buenos Aires | 2021-07-05 |
| Study of Gam-COVID-Vac in Adolescents (NCT04954092) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2021-07-05 |
| A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma (NCT04990271) | Chengdu Kanghong Biotech Co., Ltd. | 2021-07-05 |
| Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen (NCT04839965) | Ampio Pharmaceuticals. Inc. | 2021-07-05 |
| A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma (NCT04669171) | Enterome | 2021-07-05 |
| Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) (NCT04959344) | LimmaTech Biologics AG | 2021-07-05 |
| Efficacy and Safety of ES16001 in Patients With COVID-19 (NCT05525182) | Genencell Co. Ltd. | 2021-07-05 |
| Niraparib and Bevacizumab Maintenance Therapy in Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor (NCT04734665) | Yonsei University | 2021-07-05 |
| Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer (NCT04743934) | Andrew McDonald | 2021-07-02 |
| The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer (NCT05000554) | The First Hospital of Jilin University | 2021-07-02 |
| Avo In R/R And Previously Untreated MCL (NCT04855695) | Austin I Kim | 2021-07-02 |
| Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer (NCT05292742) | Fujian Medical University Union Hospital | 2021-07-02 |
| Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study (NCT04900623) | Jonathan Schoenfeld, MD, MPH | 2021-07-02 |
| Chinese Medicine for Patients With LCOVID-19 Symptoms (NCT04924881) | Chinese University of Hong Kong | 2021-07-02 |
| Phase II Study of Daratumumab Pre-Mobilization and Post-ASCT in Multiple Myeloma (NCT04230031) | Wake Forest University Health Sciences | 2021-07-02 |
| Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer (NCT04696575) | Roswell Park Cancer Institute | 2021-07-02 |
| Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D (NCT04729296) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2021-07-01 |
| Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety. (NCT04730895) | Kafrelsheikh University | 2021-07-01 |
| Angiotensin 2 for Hepatorenal Syndrome (NCT04048707) | University of California, Los Angeles | 2021-07-01 |
| Psycho-educational Tool to Prevent Psychological Sequelae Following Paediatric Intensive Care Unit Admission (NCT04635449) | Imperial College Healthcare NHS Trust | 2021-07-01 |
| Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease (NCT04926272) | First Affiliated Hospital of Fujian Medical University | 2021-07-01 |
| Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma (NCT04961788) | Shanghai Zhongshan Hospital | 2021-07-01 |
| Oral Capsule Faecal Microbiota Transplantation for CPE Decolonization (NCT04746222) | Tan Tock Seng Hospital | 2021-07-01 |
| Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification (NCT04880811) | Peking University | 2021-07-01 |
| CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer (NCT05143151) | Shenzhen University General Hospital | 2021-07-01 |
| Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients (NCT05216562) | Dermama Bioteknologi Laboratorium | 2021-07-01 |